Litigation Details for Acerta Pharma B.V. v. Cipla Limited (D. Del. 2024)
✉ Email this page to a colleague
Acerta Pharma B.V. v. Cipla Limited (D. Del. 2024)
Docket | ⤷ Sign Up | Date Filed | 2024-05-16 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:1 Patent Infringement | Assigned To | |
Jury Demand | None | Referred To | |
Patents | 10,272,083 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Acerta Pharma B.V. v. Cipla Limited
Biologic Drugs cited in Acerta Pharma B.V. v. Cipla Limited
The biologic drugs covered by the patent cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for Acerta Pharma B.V. v. Cipla Limited (D. Del. 2024)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2024-05-16 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,272,083; 11,059,829. (oam)… 16 May 2024 1:24-cv-00587 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |